1
by Brasure, Michelle
Published 2014
Agency for Healthcare Research and Quality

2
Published 2024
Springer Nature Singapore

3
by Snyder, David L., Sullivan, Nancy, Schoelles, Karen M.
Published 2012
AHRQ, Technology Assessment Program
... of products. We included only those products indicated for chronic wounds. We note that FDA does not refer...

4
by Wells, George A.
Published 2016
Canadian Agency for Drugs and Technologies in Health
... of currently available and emerging regimens for the treatment of chronic hepatitis C (CHC) infection...

5
by Totten, Annette M.
Published 2019
Agency for Healthcare Research and Quality

6
by Skelly, Andrea Clare
Published 2018
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

7
Published 2024
Springer International Publishing
Table of Contents: ...PART I – BASIC CONSIDERATIONS: -- Evolution of Interventional Pain Management -- Chronic Pain...

8
by Kansagara, Devan
Published 2014
Department of Veterans Affairs, Health Services Research and Development Service
... and tumor markers mainly in patients with chronic hepatitis B or liver cirrhosis. However, recommendations...

9
by Gray, Casey, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
...Chronic pain serves no biological purpose in contrast with acute pain, which warns of disease...

10
Published 2015
Canadian Agency for Drugs and Technologies in Health

11
by Smith, M. E. Beth
Published 2014
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

12
Published 2014
Canadian Agency for Drugs and Technologies in Health
... to inhibit viral replication in patients with chronic hepatitis C (CHC). Approximately half of patients...

13
by Aungst, Heide
Published 2019
Patient-Centered Outcomes Research Institute
... helpful: diabetes management, high use of health care, chronic pain management, group health care visits...

14
by Chou, Roger
Published 2014
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
... or in other subgroups. CONCLUSIONS: Evidence on long-term opioid therapy for chronic pain is very limited...

15
by Gartlehner, Gerald
Published 2017
Agency for Healthcare Research and Quality (US)
... trials that provided information on the primary prevention of chronic conditions with hormone therapy...

16
Published 2015
Canadian Agency for Drugs and Technologies in Health
... of omalizumab (OMA) for the treatment of chronic idiopathic urticaria (CIU) in adults and adolescents who remain...

17
by Murphy, Gaetanne
Published 2014
Canadian Agency for Drugs and Technologies in Health

18
by Kansagara, Devan
Published 2017
Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service

19
by Shaw, Ryan J.
Published 2013
Department of Veterans Affairs
... barrier to the provision of comprehensive chronic disease care and provides an impetus to develop and test...

20
Published 2022
World Health Organization
...Treatment of adolescents and children with chronic HCV infection, and HCV simplified service...